RAAPID, Inc. Secures Series A Funding
RAAPID, Inc., a Louisville-based company specializing in AI-driven risk adjustment solutions, has announced the closure of its Series A funding round on March 17, 2026. The company, which focuses on transforming RADV audit risk with explainable AI, received an undisclosed amount of investment.
Investors and Leadership
The funding round was led by UPMC Enterprises, the innovation and venture capital arm of UPMC. Additionally, M12, Microsoft's venture fund, also participated in this round. RAAPID, Inc. was co-founded by Chetan Parikh, who serves as the CEO, and Vatsal Ghiya, the CMO. The company has gained recognition for its high accuracy in HCC coding and MEAT evidence validation.
Company Background
RAAPID, Inc. has been acknowledged by Modern Healthcare as a 2025 Best in Business honoree in Healthcare IT. The company's core technology aims to provide 98% accuracy in Hierarchical Condition Category (HCC) risk adjustment, along with robust MEAT (Monitor, Evaluate, Assess, Treat) evidence validation and extrapolation protection.
Strategic Use of Funds
The newly secured funds are expected to support RAAPID, Inc. in expanding its technological capabilities and extending its market reach. While specific plans for the use of funds were not detailed, such investments typically focus on enhancing product development, scaling operations, and possibly expanding into new geographic markets.
Conclusion
The Series A funding round marks a significant step for RAAPID, Inc. as it continues to innovate within the healthcare IT sector. With backing from prominent investors like UPMC Enterprises and M12, the company is well-positioned to further its mission of reducing audit risks and improving the accuracy of risk adjustment in the healthcare industry.
For more information, visit RAAPID's website.